This article is published in the forthcoming issue.

Unmasking the psychiatric impact of ketamine in burn patients: Elevated risk of depression and acute stress reactions

Psychiatric impact of ketamine in burn patients

Authors

Keywords:

Ketamine, Burn Injury, Depression, Acute Stress Reaction

Abstract

Background/Aim: Ketamine is frequently administered for analgesia and sedation during burn dressing changes, but its potential psychological impact remains a concern. This study assessed whether ketamine exposure during early burn care is associated with subsequent depression, acute stress reaction (ASR), or post-traumatic stress disorder (PTSD) in patients with major burns.

Methods: A retrospective cohort study was conducted using the TriNetX global health research network. Patients aged 12 to 90 years with burn injuries involving ≥10% total body surface area were included. Two cohorts were defined according to ketamine exposure within one month of injury. Propensity score matching (1:1) was performed for age, sex, and race, yielding 3,518 patients per group. Outcomes were evaluated over one year using diagnostic codes for depression, ASR, and PTSD. Analyses included risk estimates, odds ratios, Kaplan-Meier methods, and hazard ratios.

Results: Ketamine exposure was associated with a higher risk of depression (4.9% vs. 3.8%; odds ratio 1.30; hazard ratio 1.24; P = 0.012) and ASR (2.0% vs. 0.8%; odds ratio 2.56; hazard ratio 2.41; P < 0.001). PTSD incidence was similar between cohorts (0.6% vs. 0.6%; odds ratio 1.03; hazard ratio 0.99; P = 0.952).

Conclusion: In patients with major burns, ketamine exposure during early care was associated with increased risks of depression and ASR, but not PTSD. These findings support routine psychological screening and follow-up when ketamine is used for burn-related analgesia and sedation.

Downloads

Download data is not yet available.

References

Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth. 1996;77(4):441-4.

Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics ketamine and phencyclidine selectively reduce excitation of mammalian central neurones by N-methyl-aspartate. Br J Pharmacol. 1983;79(2):565-75.

Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449-61.

Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8(3):283-90.

Fauerbach JA, Lawrence JW, Munster AM. Psychological distress following major burn injury. Psychosom Med. 1996;58(2):194-203.

Thombs BD, Bresnick MG, Magyar-Russell G. Depression in survivors of burn injury: a systematic review. Gen Hosp Psychiatry. 2006;28(6):494-502.

Patterson DR, Everett JJ, Bombardier CH, Questad KA, Lee VK, Marvin JA. Psychiatric complications during acute burn rehabilitation. J Trauma. 1993;34(1):73-9.

Fauerbach JA, Heinberg LJ, Lawrence JW, Bryant AG, Richter L, Spence RJ. Coping with body image changes following a disfiguring burn injury. Health Psychol. 2002;21(2):115-21.

Van Loey NE, Van Son MJ. Psychopathology and psychological problems in patients with burn scars: epidemiology and management. Am J Clin Dermatol. 2003;4(4):245-72.

Schönenberg M, Reichwald U, Domes G, Badke A, Hautzinger M. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. J Psychopharmacol. 2008;22(5):493-7.

Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 1999;20(2):106-18.

McGhee LL, Maani CV, Garza TH, Slater TM, Petz LN, Fowler M. The correlation between ketamine and post-traumatic stress disorder in burned service members. J Burn Care Res. 2008;29(6):S161.

Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, et al. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016;173(8):816-26.

Li HY, Xu WJ, Wang YM, Xie S, Wang HL. Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis. Front Psychiatry. 2025;16:1476449.

Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov. 2017;16(7):472-86.

Graphical Abstract

Downloads

Published

2026-06-11

Issue

Section

Research Article

How to Cite

1.
Lee D, Beyene E, Monroe D, McMillan E, Lyles S, Creavalle M, Zelelew B, Gillani SF, Bisrat M, Zinabu S, Michael M. Unmasking the psychiatric impact of ketamine in burn patients: Elevated risk of depression and acute stress reactions: Psychiatric impact of ketamine in burn patients. J Surg Med [Internet]. 2026 Jun. 11 [cited 2026 Jun. 13];10(6):e8322. Available from: https://jsurgmed.com/article/view/8322